Q² Solutions Expands Capabilities in Singapore
By Default Author
Q² Solutions to Expand Genomics Capabilities and Form a Translational Sciences and Innovation Laboratory, Creating 750 New Jobs in North Carolina over the next 10 years
By Default Author
Q² Solutions Welcomes Dr. Bob Bailer as Head of Vaccines Business Unit
By Default Author
Q² Solutions, HSBlox and R3 announce successful Proof-of-Concept of blockchain-based solution
By Default Author
Q² Solutions Announces Deployment of Next Generation Flow Cytometry Services
By Default Author
Q² Solutions | EA Genomics launches Illumina’s TruSight™ Oncology 500 Tumor Profiling assay services for the analysis of Tumor Mutational Burden
By Default Author
Q² Solutions Expands Genomics Capabilities in Europe
By Default Author
Q² Solutions and KingMed Partner to Develop In Vitro Diagnostics and Companion Diagnostics in China
By Default Author
Q² Solutions | EA Genomics receives New York State Clinical Laboratory Certification
By Default Author
Q² Solutions Welcomes Michael Brown as Immunoanalytical Scientific Director and Site Lead
By Default Author